van Kralingen Christa, Kho Dan Ting, Costa Jessica, Angel Catherine Elizabeth, Graham E Scott
Centre for Brain Research, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
School of Biological Sciences, Faculty of Sciences, University of Auckland, Auckland, New Zealand.
PLoS One. 2013 Dec 19;8(12):e84269. doi: 10.1371/journal.pone.0084269. eCollection 2013.
Astrocytes have critical roles in the human CNS in health and disease. They provide trophic support to neurons and are innate-immune cells with keys roles during states-of-inflammation. In addition, they have integral functions associated with maintaining the integrity of the blood-brain barrier.
We have used cytometric bead arrays and xCELLigence technology to monitor the to monitor the inflammatory response profiles and astrocyte compromise in real-time under various inflammatory conditions. Responses were compared to a variety of inflammatory cytokines known to be released in the CNS during neuroinflammation. Astrocyte compromise measured by xCELLigence was confirmed using ATP measurements, cleaved caspase 3 expression, assessment of nuclear morphology and cell death.
Inflammatory activation (IL-1β or TNFα) of astrocytes results in the transient production of key inflammatory mediators including IL-6, cell surface adhesion molecules, and various leukocyte chemoattractants. Following this phase, the NT2-astrocytes progressively become compromised, which is indicated by a loss of adhesion, appearance of apoptotic nuclei and reduction in ATP levels, followed by DEATH. The earliest signs of astrocyte compromise were observed between 24-48 h post cytokine treatment. However, significant cell loss was not observed until at least 72 h, where there was also an increase in the expression of cleaved-caspase 3. By 96 hours approximately 50% of the astrocytes were dead, with many of the remaining showing signs of compromise too. Numerous other inflammatory factors were tested, however these effects were only observed with IL-1β or TNFα treatment.
Here we reveal direct sensitivity to mediators of the inflammatory milieu. We highlight the power of xCELLigence technology for revealing the early progressive compromise of the astrocytes, which occurs 24-48 hours prior to substantive cell loss. Death induced by IL-1β or TNFα is relevant clinically as these two cytokines are produced by various peripheral tissues and by resident brain cells.
星形胶质细胞在人类中枢神经系统的健康和疾病状态中发挥着关键作用。它们为神经元提供营养支持,并且是炎症状态下具有关键作用的固有免疫细胞。此外,它们还具有与维持血脑屏障完整性相关的重要功能。
我们使用细胞计数珠阵列和xCELLigence技术在各种炎症条件下实时监测炎症反应谱和星形胶质细胞损伤情况。将反应与已知在神经炎症期间在中枢神经系统中释放的多种炎症细胞因子进行比较。通过ATP测量、裂解的半胱天冬酶3表达、核形态评估和细胞死亡来确认通过xCELLigence测量的星形胶质细胞损伤。
星形胶质细胞的炎症激活(IL-1β或TNFα)导致关键炎症介质的短暂产生,包括IL-6、细胞表面粘附分子和各种白细胞趋化因子。在此阶段之后,NT2-星形胶质细胞逐渐受损,表现为粘附丧失、凋亡核出现和ATP水平降低,随后死亡。在细胞因子处理后24 - 48小时观察到星形胶质细胞损伤的最早迹象。然而,直到至少72小时才观察到明显的细胞损失,此时裂解的半胱天冬酶3的表达也增加。到96小时时,大约50%的星形胶质细胞死亡,许多剩余的细胞也显示出受损迹象。测试了许多其他炎症因子,然而这些效应仅在IL-1β或TNFα处理时观察到。
在这里,我们揭示了对炎症环境介质的直接敏感性。我们强调了xCELLigence技术在揭示星形胶质细胞早期渐进性损伤方面的能力,这种损伤发生在实质性细胞损失前24 - 48小时。由IL-1β或TNFα诱导的死亡在临床上具有相关性,因为这两种细胞因子由各种外周组织和驻留脑细胞产生。